Topics

Drug Combo No Better in MRSA Blood Infections, Ups Risk

06:00 EST 11 Feb 2020 | Medscape

Adding a beta-lactam to standard therapy for MRSA bacteremia does not improve outcomes and appears to up the risk for kidney injury, data from a randomized controlled trial showed.
Medscape Medical News

Original Article: Drug Combo No Better in MRSA Blood Infections, Ups Risk

NEXT ARTICLE

More From BioPortfolio on "Drug Combo No Better in MRSA Blood Infections, Ups Risk"

Quick Search

Relevant Topic

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...